You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoantigen Vaccines

Showing 1 - 25 of 2,580
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023

Tumors Trial in Tijuana (Neoantigen Peptides)

Recruiting
  • Neoplasms
  • Neoantigen Peptides
  • Tijuana, Baja California, Mexico
    Instituto de Medicina Regenerativa
Jul 22, 2022

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jan 12, 2022

Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)

Recruiting
  • Pancreatic Tumor
  • Personalized neoantigen vaccine
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2022

A Study of Personalized Neoantigen Cancer Vaccines

Completed
  • Non Small Cell Lung Cancer
  • +4 more
  • Blood collection for research (next-generation sequencing [NGS])
  • Blood collection for research (HLA typing)
  • Chicago, Illinois
  • +4 more
Sep 10, 2020

Resectable Esophageal Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Esophageal Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University
Mar 23, 2022

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2022

Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Baltimore, Saint Louis (biological, device, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Personalized neoantigen DNA vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Sep 15, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

Solid Tumor Trial in Beijing (Personalized neoantigen tumor vaccine)

Not yet recruiting
  • Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 28, 2022

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Recruiting
  • Gastric Cancer
  • +2 more
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, Beijing, China
    PLA General Hospital
Jan 27, 2022

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

High Risk Cancer, Pancreatic Cancer Trial in Baltimore (KRAS peptide vaccine)

Recruiting
  • High Risk Cancer
  • Pancreatic Cancer
  • KRAS peptide vaccine
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jun 1, 2022

Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Active, not recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital
Nov 15, 2021

Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

Recruiting
  • Melanoma (Skin)
  • Non-Small-Cell Lung Carcinoma
  • GAd-PEV
  • MVA-PEV
  • Charleroi, Belgium
  • +6 more
Feb 23, 2022

Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung Trial in Shenzhen (Neoantigen loaded DC vaccine)

Unknown status
  • Carcinoma, Non-Small Cell Lung
  • Carcinoma, Small Cell Lung
  • Neoantigen loaded DC vaccine
  • Shenzhen, Guangdong, China
    Shenzhen People's Hospital
Mar 10, 2019

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022